Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.03/Share
August 6, 2015 6:36 AM EDTOncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.03), versus ($0.05) reported last year.
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
... More